1. Home
  2. EYPT vs SGU Comparison

EYPT vs SGU Comparison

Compare EYPT & SGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SGU
  • Stock Information
  • Founded
  • EYPT 1987
  • SGU 1995
  • Country
  • EYPT United States
  • SGU United States
  • Employees
  • EYPT N/A
  • SGU N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SGU Other Specialty Stores
  • Sector
  • EYPT Industrials
  • SGU Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • SGU Nasdaq
  • Market Cap
  • EYPT 439.4M
  • SGU 391.0M
  • IPO Year
  • EYPT 2005
  • SGU 1995
  • Fundamental
  • Price
  • EYPT $9.17
  • SGU $12.20
  • Analyst Decision
  • EYPT Strong Buy
  • SGU
  • Analyst Count
  • EYPT 8
  • SGU 0
  • Target Price
  • EYPT $27.29
  • SGU N/A
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • SGU 20.5K
  • Earning Date
  • EYPT 11-07-2024
  • SGU 12-04-2024
  • Dividend Yield
  • EYPT N/A
  • SGU 5.68%
  • EPS Growth
  • EYPT N/A
  • SGU 818.35
  • EPS
  • EYPT N/A
  • SGU 1.24
  • Revenue
  • EYPT $45,713,000.00
  • SGU $1,792,705,000.00
  • Revenue This Year
  • EYPT N/A
  • SGU N/A
  • Revenue Next Year
  • EYPT N/A
  • SGU N/A
  • P/E Ratio
  • EYPT N/A
  • SGU $9.84
  • Revenue Growth
  • EYPT 7.50
  • SGU N/A
  • 52 Week Low
  • EYPT $5.86
  • SGU $9.64
  • 52 Week High
  • EYPT $30.99
  • SGU $14.76
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 38.25
  • SGU 59.69
  • Support Level
  • EYPT $11.26
  • SGU $11.71
  • Resistance Level
  • EYPT $12.23
  • SGU $12.16
  • Average True Range (ATR)
  • EYPT 0.97
  • SGU 0.40
  • MACD
  • EYPT -0.30
  • SGU 0.06
  • Stochastic Oscillator
  • EYPT 3.24
  • SGU 90.07

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SGU Star Group L.P.

Star Group LP is a company engaged in providing home heating products and services to residential and commercial customers. It offers heating and air conditioning equipment, as well as home security and plumbing services. The company also sells diesel fuel, gasoline, and home heating oil. Geographically, the company operates in U.S.

Share on Social Networks: